Home/ Supplements/ Lysine/ L-Lysine Powder 960 mg

L-Lysine Powder 960 mg

product on market Powder Carlson Safety: 100/100
100/100

This product looks safe

  • No ingredients exceed tolerable upper intake levels
  • Limited research evidence available for ingredients
B Label Compliance Grade
Label

Product Label

Label for L-Lysine Powder 960 mg
Open Full PDF View on NIH DSLD →
Details

Label Data

1.2 Gram(s)
Serving Size
83
Servings
Amino acid/Protein
Product Type
0%
Evidence Coverage
Ingredients

Supplement Facts — Evidence Check

960 mg
Market median: 500.0mg (159 products)
Claims

Label Claims — Verification

Unverified Nutrient
Unverified All Other
Unverified Structure/Function
Info

Product Information

Directions for Use

Directions: Adults: take 1/2 teaspoonful (one level scoopful) daily mixed into food or liquid.

Warnings & Precautions

Warning: Pregnant or lactating women or those with kidney problems should consult with their doctor before using this product.

Formulation Notes

Free-form amino acid

Immune function Stress support Tissue health

Gluten-free Milk/Casein-free

L-Lysine is an essential amino acid that promotes immune and tissue health, provides stress support, and is an important building block for protein.

Potency & quality guaranteed An FDA Regulated Facility

This product may vary in appearance and consistency.

Additional Information

Keep bottle tightly closed. Store away from heat and moisture.

Providing the highest quality nutritional supplements since 1965

This product is sold by weight not volume.

Metadata

Product Details

UPC / SKU0 88395 06885 0
DSLD Entry Date2021-01-22
Product TypeAmino acid/Protein
FormPowder
BrandCarlson
DSLD ID241777
Data Updated2026-04-11
Research

Research Evidence

3
Research Sources
74
Avg Quality
3
Meta Analysis
A Antifibrinolytics (lysine analogues) for the prevention of bleeding in people with haematological disorders
Meta Analysis The Cochrane database of systematic reviews 2026 PubMed DOI
B Antifibrinolytics (lysine analogues) for the prevention of bleeding in people with haematological disorders
Meta Analysis The Cochrane database of systematic reviews 2016 PubMed DOI
B Antifibrinolytics (lysine analogues) for the prevention of bleeding in patients with haematological disorders
Meta Analysis The Cochrane database of systematic reviews 2013 PubMed DOI
View all evidence for Lysine →
Compare

Similar Products

View all Lysine products →

This product page is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before taking any supplement.